Dr. Haifeng Xu 徐海峰
Chief Physician
Department of Interventional Therapy, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive endovascular interventional therapy for primary liver cancer, metastatic liver cancer, hepatic hemangioma, and lung cancer. Interventional treatment for non-vascular obstructions in the esophagus and biliary tract.
Dr. Haifeng Xu is a Chief Physician in the Department of Interventional Therapy at Peking University Cancer Hospital.
Name order: in Chinese the family name comes first (Xu Haifeng). Papers usually list the name as Haifeng Xu or Xu H.
Selected publications
45 papers on PubMed matched by name and affiliation; 0 as first or senior author since 2016. Most recent first- or senior-author papers:
- Chin Med J (Engl), 2014 (first author): Symptomatic pulmonary lipiodol embolism after transarterial chemoembolization for hepatic malignant tumor: clinical presentation and chest imaging findings. PubMed 24534221
- Zhonghua Yi Xue Za Zhi, 2013 (first author): [Angiographic findings and interventional therapy for post-pancreaticoduodenectomy hemorrhage]. PubMed 23578457
- Zhonghua Yi Xue Za Zhi, 2011 (first author): [Interventional therapy of hepatic artery-portal vein fistula with gelatin sponge and lipiodol]. PubMed 21609644
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion